BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32074407)

  • 21. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
    Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
    Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
    Mori M; Akashi-Tanaka S; Suzuki S; Daniels MI; Watanabe C; Hirose M; Nakamura S
    Breast Cancer; 2017 Jan; 24(1):104-110. PubMed ID: 26942415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
    Liew ALF; Lim HMY; Fok ECM; Loke SC; Tan EY; Chong BK; Lee YS; Chan PMY; Chotai N
    Breast J; 2022; 2022():7087408. PubMed ID: 35711887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting.
    Tennant SL; James JJ; Cornford EJ; Chen Y; Burrell HC; Hamilton LJ; Girio-Fragkoulakis C
    Clin Radiol; 2016 Nov; 71(11):1148-55. PubMed ID: 27296475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of contrast-enhanced spectral mammography compared with MRI for invasive breast cancers: Prospective study in population of predominantly underrepresented minorities.
    Lee SC; Hovanessian-Larsen L; Stahl D; Cen S; Lei X; Desai B; Yamashita M
    Clin Imaging; 2021 Dec; 80():364-370. PubMed ID: 34509973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
    Tang S; Xiang C; Yang Q
    Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the Diagnostic Values of Dynamic Enhanced Magnetic Resonance Imaging,Digital Breast Tomosynthesis,and Digital Mammography for Early Breast Cancer].
    Xu AQ; Weng XB; Zheng J; Li ZQ; Wang XL; Zhang SJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):667-672. PubMed ID: 31699198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI in the differential diagnosis of primary architectural distortion detected by mammography.
    Si L; Zhai R; Liu X; Yang K; Wang L; Jiang T
    Diagn Interv Radiol; 2016; 22(2):141-50. PubMed ID: 26899149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis.
    Cheung YC; Lin YC; Wan YL; Yeow KM; Huang PC; Lo YF; Tsai HP; Ueng SH; Chang CJ
    Eur Radiol; 2014 Oct; 24(10):2394-403. PubMed ID: 24928280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy.
    James J
    Br J Radiol; 2022 Apr; 95(1132):20211287. PubMed ID: 35015574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
    Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Evaluation of Contrast-Enhanced Spectral Mammography and Digital Breast Tomosynthesis for Diagnosing and Treating Breast Cancer.
    Yang D; Gong F
    Med Sci Monit; 2023 Dec; 29():e941880. PubMed ID: 38087777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.
    Sorin V; Yagil Y; Shalmon A; Gotlieb M; Faermann R; Halshtok-Neiman O; Sklair-Levy M
    Acad Radiol; 2020 Sep; 27(9):1234-1240. PubMed ID: 31812577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis--Comparison to contrast-enhanced breast MRI.
    Chou CP; Lewin JM; Chiang CL; Hung BH; Yang TL; Huang JS; Liao JB; Pan HB
    Eur J Radiol; 2015 Dec; 84(12):2501-8. PubMed ID: 26456307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
    Fallenberg EM; Dromain C; Diekmann F; Renz DM; Amer H; Ingold-Heppner B; Neumann AU; Winzer KJ; Bick U; Hamm B; Engelken F
    Breast Cancer Res Treat; 2014 Jul; 146(2):371-81. PubMed ID: 24986697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced spectral mammography: comparison with conventional mammography and histopathology in 152 women.
    Luczyńska E; Heinze-Paluchowska S; Dyczek S; Blecharz P; Rys J; Reinfuss M
    Korean J Radiol; 2014; 15(6):689-96. PubMed ID: 25469079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
    Tardivel AM; Balleyguier C; Dunant A; Delaloge S; Mazouni C; Mathieu MC; Dromain C
    Breast J; 2016 Sep; 22(5):520-8. PubMed ID: 27345656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients.
    Feng L; Sheng L; Zhang L; Li N; Xie Y
    Contrast Media Mol Imaging; 2022; 2022():4224701. PubMed ID: 35585943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.